TWi Biotechnology, Inc. (TPEX:6610)
Taiwan · Delayed Price · Currency is TWD 26.15
+0.05 (0.19%)
Jul 30, 2026, 1:59 PM CST
TWi Biotechnology Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -202.37 | -164.81 | -170.68 | -76.18 | -15.3 |
Depreciation & Amortization | 35.32 | 26.84 | 9.74 | 10.33 | 11.08 |
Other Amortization | - | - | 0 | 0.02 | 0.02 |
Stock-Based Compensation | - | -0.88 | 5.5 | 3.08 | - |
Other Operating Activities | -155.14 | -324.72 | -0.01 | - | - |
Change in Accounts Receivable | -0.28 | -0.45 | 0.13 | 3.56 | -3.41 |
Change in Inventory | - | - | - | - | 2.34 |
Change in Accounts Payable | 37.22 | 4.76 | - | - | - |
Change in Unearned Revenue | - | - | - | - | -30.07 |
Change in Other Net Operating Assets | -1.73 | -2.46 | 21.1 | -1.06 | 0.87 |
Operating Cash Flow | -286.99 | -461.72 | -134.22 | -60.24 | -34.46 |
Operating Cash Flow Growth | - | - | - | - | - |
Capital Expenditures | -0.41 | -0.31 | - | - | -0.23 |
Sale (Purchase) of Intangibles | -5.46 | -436.91 | - | - | -30 |
Investment in Securities | 48.8 | 123.05 | -171.85 | 34.3 | 191.9 |
Other Investing Activities | -0.03 | - | - | - | -0.03 |
Investing Cash Flow | 42.9 | -314.17 | -171.85 | 34.3 | 161.64 |
Short-Term Debt Issued | - | 10 | - | - | 7.6 |
Total Debt Issued | - | 10 | - | - | 7.6 |
Short-Term Debt Repaid | -10 | - | - | - | -7.6 |
Long-Term Debt Repaid | -2.66 | -2.37 | -2.5 | -2.5 | -2.46 |
Total Debt Repaid | -12.66 | -2.37 | -2.5 | -2.5 | -10.06 |
Net Debt Issued (Repaid) | -12.66 | 7.63 | -2.5 | -2.5 | -2.46 |
Issuance of Common Stock | 180 | 954 | 300 | - | - |
Financing Cash Flow | 167.34 | 961.63 | 297.5 | -2.5 | -2.46 |
Net Cash Flow | -76.75 | 185.75 | -8.57 | -28.44 | 124.72 |
Free Cash Flow | -287.4 | -462.03 | -134.22 | -60.24 | -34.69 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | - | - | - | - | -52.24% |
Free Cash Flow Per Share | -1.48 | -2.52 | -1.83 | -0.89 | -0.51 |
Levered Free Cash Flow | -125.33 | -701.83 | -68.48 | -40.34 | -88.91 |
Unlevered Free Cash Flow | -125.23 | -701.73 | -68.43 | -40.31 | -88.85 |
Cash Interest Paid | 0.17 | 0.16 | 0.09 | 0.05 | 0.09 |
Cash Income Tax Paid | - | 0.08 | - | - | - |
Change in Working Capital | 35.21 | 1.85 | 21.24 | 2.5 | -30.26 |